Chest wall invasive non-small cell lung cancer: Patterns of failure and implications for a revised staging system
- 20 Downloads
Background: To assess outcomes and patterns of failure for chest wall invasive non-small cell lung cancer (T3 or IIIA NSCLC), data were acquired prospectively on 47 consecutive patients at a single institution over 6 years.
Methods: Preresectional stagings included bone scan, head and chest/abdominal computed tomography, and mediastinoscopy. There were 25 superior sulcus tumors (radiation and/or chemotherapy followed by resection) and 22 other chest wall invasive NSCLCs (resection alone).
Results: There were no perioperative deaths. Seventeen patients (36%) had an operative complication (median length of stay increased from 7 to 12 days; p<0.05). A complete pathologic resection was achieved for 44 of 47 patients (94%). The median survival was 38 months (actuarial 2- and 5-year survival rates of 62% and 50%, respectively). Median lengths of survival for superior sulcus and other chest wall tumors were 36 and >60 months, respectively. Significant univariate predictors of decreased overall and cancer-free survival were poor performance status, positive margins, and positive lymph nodes. Recurrence was observed in 22 of 47 patients (46%) at a median of 8 months (range 2–24); patterns of failure were in the ipsilateral chest (n=2; 4%) and at a distant site (n=15; 32%) or both (n=5; 11%).
Conclusions: The operative risk for chest wall invasive NSCLC is acceptable, even after neoadjuvant therapy, allowing for a 94% complete resection rate. The survival of this subset of stage IIIA patients may warrant a reappraisal of the international staging system.
Key WordsChest wall resection Non-small cell lung cancer Superior sulcus tumors Pancoast tumors
Unable to display preview. Download preview PDF.
- 1.Pancoast HK. Importance of careful roentgenray investigations of apical chest tumors.JAMA 1924;83:1407–11.Google Scholar
- 2.Pancoast H. Superior pulmonary sulcus tumor: tumor characterized by pain, Horner's syndrome, destruction of bone and atrophy of hand muscles.JAMA 1932;99:1391–6.Google Scholar
- 3.Charcack WM, MacCallum JD. Pancoast tumor: five-year survival without recurrence or metastases following radical resection and irradiation.J Thorac Surg 1956;31:535–42.Google Scholar
- 4.Shaw RR, Paulson DL, Kee JL Jr. Treatment of the superior sulcus tumor by irradiation followed by resection.Ann Surg 1961;154:29–40.Google Scholar
- 5.Mountain CF. A new international staging system for lung cancer.Chest 1986;89(suppl):225–33.Google Scholar
- 12.Ginsberg RJ, Martini N, Armstrong JG, et al. Influence of surgical resection and brachytherapy on superior sulcus tumor. Abstract presented at the 30th annual meeting of the Society of Thoracic Surgeons, 1994.Google Scholar
- 22.Mishina H, Suemasu K, Yoneyama T, et al. Surgical pathology and prognosis of the combined resection of chest wall and lung in lung cancer.Jpn J Clin Oncol 1978;8:161–8.Google Scholar
- 24.Merlier M, Rojas-Miranda A, Silbert D, Ranson-Bitker B. The staging issue: unification of criteria. In: Delarue N, Eschapasse H, eds.International trends in general thoracic surgery. Philidelphia: WB Saunders, 1985:241.Google Scholar
- 26.Naruke T, Tomoyuki G, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system.J Thorac Cardiovasc Surg 188;96:440–7.Google Scholar